Healthcare >> CEO Interviews >> September 13, 2002
Prior to becoming CEO of Sunesis in May 2000, JAMES W. YOUNG, PhD,
served as Senior Vice President, Research and Development, and as Group
Vice President at ALZA Corporation. Before joining ALZA, Dr. Young had
been President of the Pharmaceuticals Division of Affymax, N.V. and Sr.
Vice President and General Manager of the Pharmaceuticals Division at
Sepracor Corp. Earlier, he was Vice President for Research at Zoecon
Corporation/Sandoz Crop Protection Corporation. Dr. Young earned a
Bachelor of Science degree in chemistry from Fordham University in New
York and a PhD in organic chemistry from Cornell University. Profile
Mr. Young: Sunesis is a leading discovery-based pharmaceutical company
that applies its breakthrough fragment assembly technologies to
